N-Acetyl Cysteine PCD Pharma Franchise Company
Cafoli Lifecare offers N-Acetyl Cysteine (NAC) to its PCD franchise partners, currently as 1 tablet formulation manufactured at a WHO-GMP certified facility, with district-wise monopoly rights.
What is N-Acetyl Cysteine?
N-Acetyl Cysteine is a derivative of the amino acid L-cysteine. It acts as a mucolytic by breaking the disulphide bonds in mucus glycoproteins, reducing sputum viscosity, and it is a precursor of glutathione, the body's principal intracellular antioxidant. More information is available on PubChem.
Therapeutic Applications
NAC is used as a mucolytic in chronic bronchitis and COPD, as an antioxidant adjunct in liver and kidney conditions, and as the standard antidote in paracetamol overdose (in hospital settings). Prescribers include chest physicians, pulmonologists, hepatologists and nephrologists.
Why N-Acetyl Cysteine is a High-Potential Molecule for Distributors
NAC's indication set has broadened well beyond mucolysis into antioxidant and metabolic support, and it enjoys unusually strong consumer awareness for a prescription-adjacent molecule. For a partner already promoting a respiratory range, it is an easy add-on that also picks up wellness-driven counter demand.
Why Choose Cafoli Lifecare
Cafoli offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, competitive net rates and full promotional inputs, with 1000+ franchise partners across India.
References
- PubChem: Acetylcysteine
- MedlinePlus: Acetylcysteine
Our formulations of N-Acetyl Cysteine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: